Simplify Logo

Full-Time

Project Manager

Process Automation, Consultant

Posted on 6/27/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Expert

Bridgewater Township, NJ, USA

This position is based in Raritan, New Jersey, United States.

Category
Project Management
Business & Strategy
Required Skills
Management
Requirements
  • B.S. required, Ph.D. preferred in technical discipline: engineering, science, or related field
  • Minimum 12 years of process, manufacturing, technology transfer experience, CAR-T experience is highly desirable
  • Experience in implementing and managing commercial process technology improvements and changes
  • Experience in integrating process unit operations into an automation platform
  • Candidate must have program management expertise in the life sciences field
  • Extensive experience in process automation technology and vendor offerings specific to commercial process platforms, cell therapy unit operations and instruments
  • Extensive knowledge in process best practices, industry standards and the latest technologies
  • Ability to think critically and demonstrated troubleshooting and problem-solving skills
  • Results driven with strong process, problem solving and critical thinking skills
  • Strong experience working in a cross-functional organization with multiple partners with competing priorities
  • Ability to plan, multitask, prioritize and be an effective and influential decision maker focused on action and implementation.
Responsibilities
  • Provide technical and program management to drive a process automation platform solution for a best-in-class CAR-T product
  • Development of an automation concept through detailed execution, planning activities, and milestone
  • Program management leadership to drive strategic plans, business cases to support selected platform concept, detailed project schedule for implementation, vendor coordination and cross-functional collaboration to ensure a seamless introduction in cGMP
  • Work collaboratively with internal and external partners to identify and drive implementation of industry-leading automation solutions
  • Drives plans for new unit operations to be evaluated and ensuring that all are able to be integrated into a process automation platform
  • Identifies and drives plans for new process technologies that result in a paradigm shift in throughput and capacity

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$750.5M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

20%

1 year growth

44%

2 year growth

101%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE